Browse 68 Biotechnology companies funded by Wellington Management. See funding amounts, founder contacts, and investment details.
Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.
Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.
Beta Bionics is a biotechnology company that provides software to reduce the burden of diabetes care.
Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s.
Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional genomics.
Nuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology.
RQ Bio is a biotechnology company that develops medicine based on potent broad-spectrum mAbs to provide immunity to viral infections.
Element Biosciences develops genomic sequencing and multiomics technologies used in drug discovery, and diagnostic applications.
Moderna Therapeutics is a biotechnology company that develops medicines and vaccines based on messenger RNA (mRNA) technology.
Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders.
Galecto is a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer.
Caldera Therapeutics is a biotech company engaged in the development of bispecific antibody CLD-423 for inflammatory bowel disease (IBD).
Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.
Crescent Biopharma is a biotechnology firm focused on developing novel precision-engineered medicines.
Nuvalent is a biopharmaceutical company that develops targeted therapies for cancer by designing small-molecule medicines.
Centessa Pharmaceuticals is a pharmaceutical company that focuses on drug development to address significant medical needs.
Cogent Biosciences is a biotechnology company that develops therapies for solid cancer tumors.
Nurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs.
Tubulis generates antibody-drug conjugates with unique properties for solid tumor indications.
Synapse Energy Economics is a consulting firm providing economic and policy analysis for the electric power sector.
Avalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.
Atsena Therapeutics is a clinical-stage gene therapy company that develops novel treatments for inherited forms of blindness.
Heartflow is a medical technology company that provides various methods of diagnosis and treatment of cardiovascular disease.
Aligos Therapeutics is discovering and developing new classes of molecules that interact directly with disease-causing modalities.
Helicore Biopharma is a biopharmaceutical company that discovers and develops novel weight-loss therapeutics.
SiteOne Therapeutics develops groundbreaking non-opioid treatments for acute, neuropathic, visceral, and musculoskeletal pain.
Ventyx is a biopharmaceutical company focused on advancing oral therapies for patients living with autoimmune and inflammatory disorders.
MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.
Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.
Scorpion Therapeutics is a clinical-stage oncology company that specializes in precision medicine for cancer patients.
Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.
CARGO Therapeutics develops an adoptive cell therapy to benefit patients from potentially curative treatment options.
Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases.
Asher Bio is a biotechnology company that specializes in the fields of therapeutics builds better immunotherapy for cancer.
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Black Diamond Therapeutics is a medical company focused on analyzing genetically defined cancers.
Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma.
Alkeus Pharmaceuticals is a Boston-based startup focused on treatments for serious ophthalmic conditions.
Boundless Bio is a precision oncology company that develops therapeutics directed against extrachromosomal DNA in aggressive cancers.
Generation Bio is a biotechnology company that develops genetic medicines to treat genetic disorders.
Chroma Medicine is a biotechnology company that develops genetic medicines for the treatment of genetic disorders.
RayzeBio is a pharmaceuticals company that develops targeted radiopharmaceutical drugs for cancer.
Blueprint Medicines develops precision therapies for genomically defined cancers and rare diseases.
Allena Pharmaceuticals develops and commercializes non-systemic protein therapeutics to treat metabolic and orphan diseases.
Freeline is a biotechnology company that develops transformative gene therapies for systemic debilitating diseases.
Synthego is a genome engineering company that enables access to CRISPR to accelerate life science research and development.
GBT is a clinical-stage biopharmaceutical company developing a therapy for sickle cell disease.
Strata Oncology is a precision oncology company dedicated to transforming cancer care.
Angitia Biopharmaceuticals develops biologic therapies for musculoskeletal diseases.
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
nChroma Bio is a cutting-edge biotechnology business that is developing targeted in vivo delivery systems as well as best-in-class cargo.
Verve Therapeutics is a clinical-stage biotechnology company developing genetic medicines for cardiovascular disease.
Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer.
NiKang Therapeutics is a biotech company focused on discovering and developing small molecule oncology medicines.
Satsuma Pharmaceuticals is a clinical-stage biopharmaceutical company engaged in developing a novel therapeutic product.
Artiva Biotherapeutics is a biotech company focused on developing and commercializing allogeneic natural killer (NK) cell therapies.
Gemini Therapeutics focuses on genetically-defined dry age-related macular degeneration (AMD) and associated rare genetic diseases.
Design Therapeutics is a biotechnology company developing a new class of therapies for serious degenerative disorders.
LianBio aims to develop and accelerate availability of paradigm-shifting medicines to patients in China.
PMV Pharmaceuticals is a developer of p53-targeted small molecule drugs for the treatment of cancer.
Atreca develops a technology to identify the set of antibodies produced during an immune response, without prior knowledge of an antigen.
Forty Seven is a clinical-stage immuno-oncology company that is developing therapies targeting cancer immune evasion pathways.
NEON Therapeutics is focused on unlocking the full potential of the immune system to recognize and attack cancer.
Nightstar is biopharmaceutical company, focused on developing gene therapies for retinal dystrophies.
View all companies funded by Wellington Management across every industry and funding stage.
View Full Wellington Management Portfolio